Nocturnal hypoxemic burden is associated with incident major adverse cardiovascular events in patients with type 2 diabetes
- PMID: 40294210
- DOI: 10.1093/eurjpc/zwaf259
Nocturnal hypoxemic burden is associated with incident major adverse cardiovascular events in patients with type 2 diabetes
Abstract
Aims: Type 2 diabetes (T2D) prevalence is globally increasing and associated with cardiovascular disease. Whether oximetry-derived nocturnal hypoxemic burden (NHB) parameters are associated with incident major adverse cardiovascular events (MACE) in a population with T2D is not known.
Methods: Overnight oximetry data from patients enrolled in the DIACORE (DIAbetes COhoRtE) sleep-disordered breathing sub-study, a prospective German cohort study of patients with T2D, was analyzed. NHB as cumulative time spent below 90% oxygen saturation (T90) as well as its composition of T90 attributed to acute desaturations (T90desaturation) and non-specific drifts in oxygen saturation (T90non-specific) was assessed. MACE was defined as a composite outcome of myocardial infarction, stroke, and cardiovascular death. Cox hazard regression analyses adjusted for potential known risk factors for atherosclerosis were conducted.
Results: The analysis population consisted of 1255 participants (41% female, mean age 67 years, mean diabetes duration 9.6 years). After a median follow-up of 6.5 years, a MACE occurred in 149 (12%) patients. T90, but not apnea-hypopnea index, was significantly associated with an increased risk of incident MACE by 48% independently of other known risk factors for atherosclerosis (Quartile 4 vs. Q1-3 adjusted HR 1.48, 95% CI [1.04; 2.12], p=0.032). In particular, T90non-specific contributed to the elevated risk for incident MACE (Q4 vs. Q1-3 adjusted HR 1.62, 95% CI [1.14-2.30], p=0.007).
Conclusion: In the present study, NHB was associated with MACE in patients with T2D and can be easily measured using oximetry. Further investigations are warranted to establish T90 reduction as a clinically meaningful treatment target.
Keywords: cardiovascular disease; hypoxemia; hypoxemic burden; sleep apnea; type 2 diabetes.
Plain language summary
Nocturnal hypoxemia is common in patients with type 2 diabetes and is linked to the development of major adverse cardiovascular events like myocardial infarction, stroke, or cardiovascular death. It can easily be measured using pulse oximeter clip and may yield a simple prognostic tool for patients with type 2 diabetes.Night time spent below 90% oxygen saturation was associated with newly diagnosed major adverse cardiovascular events independently of other known risk factors for atherosclerosis, and especially non-specific drifts in oxygen saturation contributed to the elevated risk. These non-specific drifts are common in patients with obesity.In contrast, event-based measures of sleep-disordered breathing such as apnea-hypopnea index were not associated with incident major adverse cardiovascular events.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Comment in
-
Breathing New Life into Cardiovascular Risk: Sleep Disordered Breathing and Nocturnal Hypoxia as a Hidden Threat in Type 2 Diabetes.Eur J Prev Cardiol. 2025 Jul 19:zwaf458. doi: 10.1093/eurjpc/zwaf458. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40682441 No abstract available.
Similar articles
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Matrix Metalloproteinases 7 and 10 Are Prognostic Biomarkers for Systemic Cardiovascular Risk in Individuals with Peripheral Artery Disease.Biomolecules. 2025 Jun 11;15(6):853. doi: 10.3390/biom15060853. Biomolecules. 2025. PMID: 40563493 Free PMC article.
-
Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Cochrane Database Syst Rev. 2015. PMID: 26171909
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
LinkOut - more resources
Full Text Sources